logo
Plus   Neg
Share
Email

Newell Brands Names CFO Christopher Peterson As Interim CEO - Quick Facts

Consumer goods company Newell Brands, Inc. (NWL) announced Wednesday the appointment of Executive Vice President and Chief Financial Officer Christopher Peterson as interim Chief Executive Officer, effective June 28, 2019.

Peterson succeeds President and Chief Executive Officer Michael Polk, who is retiring effective at the end of June as previously announced in mid-March. Polk has been the company's President and CEO since 2011 and a member of the Newell Brands Board of Directors since 2009.

Peterson will also continue his current role as the company's Executive Vice President and Chief Financial Officer, a role he has had since joining Newell Brands in December of 2018.

Over the past 25 years, Peterson has held key senior executive roles at Procter & Gamble, Ralph Lauren and most recently Revlon Inc. where he was Chief Operating Officer - Operations.

The company also said the search for a permanent CEO is proceeding well and the Board expects to be in a position to announce an external hire as the permanent CEO in the upcoming weeks. It retained global executive search firm Heidrick & Struggles to assist in a thorough search process.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT
>